Grufity logo
Grufity logo

Latest Aisling Capital Management LP Stock Portfolio

$476Million– No. of Holdings #13

Aisling Capital Management LP Performance:
2026 Q1: -1.9%YTD: -1.9%2025: 148.29%
Performance for 2026 Q1 is -1.9%, and YTD is -1.9%, and 2025 is 148.29%.

About Aisling Capital Management LP and 13F Hedge Fund Stock Holdings

On 2026-05-05, the fund reported it's updated stock portfolio. In the 13F Holdings report, Aisling Capital Management LP reported an equity portfolio of $476.3 Millions as of 31 Mar, 2026.

The top stock holdings of Aisling Capital Management LP are BBIO, SNDX, GLUE. The fund has invested 79.3% of it's portfolio in BRIDGEBIO PHARMA INC. (BBIO) and 6.5% of portfolio in SYNDAX PHARMACEUTICALS, INC. (SNDX).

The fund managers got completely rid off CALCIMEDICA, INC. (CALC) stocks. Aisling Capital Management LP opened new stock positions in EUPRAXIA PHARMACEUTICALS INC. (EPRX). The fund showed a lot of confidence in some stocks as they added substantially to BRIDGEBIO ONCOLOGY THERAPEUTICS (BBOT), COMPASS PATHWAYS PLC (CMPS) (CMPS) and MONTE ROSA THERAPEUTICS INC (GLUE) (GLUE).
Aisling Capital Management LP Equity Portfolio Value
Last Reported on: 05 May, 2026

Aisling Capital Management LP Annual Return Estimates Vs S&P 500

Our best estimate is that Aisling Capital Management LP made a return of -1.9% in the last quarter. In trailing 12 months, it's portfolio return was 110.12%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
eupraxia pharmaceuticals inc. (eprx)2,353,000
New stocks bought by Aisling Capital Management LP

Additions

Ticker% Inc.
bridgebio oncology therapeutics (bbot)80.3
compass pathways plc (cmps)19.52
monte rosa therapeutics inc (glue)5.66
Additions to existing portfolio by Aisling Capital Management LP

Reductions

None of the existing positions were reduced by Aisling Capital Management LP

Sold off

Ticker$ Sold
calcimedica, inc. (calc)-3,434,140
Aisling Capital Management LP got rid off the above stocks

Sector Distribution

Aisling Capital Management LP has about 95.1% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare95.1
Others4.9

Market Cap. Distribution

Aisling Capital Management LP has about 79.4% of it's portfolio invested in the large-cap and mega-cap stocks.

  • LARGE-CAP
  • SMALL-CAP
  • UNALLOCATED
Category%
LARGE-CAP79.4
SMALL-CAP14.2
UNALLOCATED4.9

Stocks belong to which Index?

About 93.4% of the stocks held by Aisling Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200093.4
Others6.6
Top 5 Winners (%)%
onkure therapeutics, inc. (okur)
42.8 %
ACRS
aclaris therapeutics inc (acrs)
24.6 %
BMEA
biomea fusion inc (bmea)
23.4 %
bicara therapeutics inc. (bcax)
18.2 %
SRRK
scholar rock holding corporation (srrk)
11.6 %
Top 5 Winners ($)$
SNDX
syndax pharmaceuticals, inc. (sndx)
3.1 M
bicara therapeutics inc. (bcax)
1.7 M
GLUE
monte rosa therapeutics inc (glue)
1.2 M
BMEA
biomea fusion inc (bmea)
0.6 M
SRRK
scholar rock holding corporation (srrk)
0.4 M
Top 5 Losers (%)%
bridgebio oncology therapeutics (bbot)
-23.7 %
URGN
urogen pharma ltd. (urgn)
-23.2 %
CMPS
compass pathways plc (cmps)
-18.5 %
MRKR
marker therapeutics, inc. (mrkr)
-12.8 %
BBIO
bridgebio pharma inc. (bbio)
-2.9 %
Top 5 Losers ($)$
BBIO
bridgebio pharma inc. (bbio)
-11.3 M
bridgebio oncology therapeutics (bbot)
-2.8 M
CMPS
compass pathways plc (cmps)
-1.8 M
URGN
urogen pharma ltd. (urgn)
-0.6 M
MRKR
marker therapeutics, inc. (mrkr)
-0.1 M

Aisling Capital Management LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Aisling Capital Management LP

Aisling Capital Management LP has 13 stocks in it's portfolio. About 99.5% of the portfolio is in top 10 stocks. BBIO proved to be the most loss making stock for the portfolio. SNDX was the most profitable stock for Aisling Capital Management LP last quarter.

Last Reported on: 05 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions